Skip to main content
logo
Century Therapeutics, Inc. (IPSC)
NASDAQ: IPSC · Real-Time Price · USD
1.610
-0.100 (-5.85%)
Oct 1, 2026, 4:00 PM EDT - Market closed

Century Therapeutics Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
-109.166.592.245.2-
Revenue Growth
-1556.76%194.81%-57.01%--
Gross Profit
-78.9313.5-100.66-90.48-91.97-75.65
Operating Income
-107.52-15.04-135.17-125.18-123.83-94.88
Net Income
-109.79-9.58-126.57-136.67-130.93-95.82
Earnings Per Share
-0.77-0.11-1.61-2.30-2.27-2.96
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
119.71117.11189.29172.74315.5222.88
Total Debt
38.6743.5753.8348.1749.4125.12
Net Cash (Debt)
81.0573.55135.46124.57266.08197.76
Net Cash Growth
-22.34%-45.70%8.75%-53.19%34.55%264.89%
Net Cash Per Share
0.570.851.722.104.616.11

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-86.76-103.88-110.14-88.3514.05-89
Capital Expenditures
-1.33-0.85-0.15-13.74-30.6-44.97
Free Cash Flow
-88.09-104.72-110.29-102.08-16.55-133.97
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
-12.36%----
Operating Margin
--13.78%-2051.39%-5600.94%-2381.82%-
Pretax Margin
--8.84%-1893.70%-6030.96%-2516.66%-
Profit Margin
--8.78%-1920.87%-6115.12%-2518.41%-
FCF Margin
--95.93%-1673.84%-4567.52%-318.37%-

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingOct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
-0.8013.0388.8858.19-